Company overview
PT Kalbio Global Medika
Name
PT Kalbio Global Medika
Entity type
PT (Limited Liability Company)
Province
Jawa Barat
Regency
Kab. Bekasi
District
Cikarang Pusat
Village
Cicau
Address
Jalan Soka Delta Silicon 3 Lippo Cikarang Blok F19 No. 002
Postal code
17530
Country
Indonesia
Primary goods traded
- 💉37.4% — Blood, human or animal, antisera, other blood fractions and immunological products (300215)
- 21.4% — Medicaments (300331)
- 🏥15.3% — Medical, surgical or dental instruments and appliances (901890)
- 14.0% — Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues (293719)
- 11.8% — Medical, surgical instruments and appliances (901831)
Main Trading Partners
| Partner | Type | Total Value | Percentage |
|---|---|---|---|
| Gan & Lee Pharmaceuticals | seller | $5,508,486 | 15.26% |
| Gangan Medical Technology Jiangsu Co., Ltd. | seller | $2,732,682 | 7.57% |
| Kalbe International Pte. Ltd. | buyer | $704,012 | 1.95% |
| Shandong Wego Prefills Pharmaceutical Packaging Co., Ltd. | seller | $604,975 | 1.68% |
| Truking Technology Limited | seller | $475,000 | 1.32% |
Loading chart...
Loading chart...
Loading chart...
Loading chart...
Loading chart...
Trade Data
| Data Source | HS Code | Description | Buyer | Buyer Country | Seller | Seller Country | ||
|---|---|---|---|---|---|---|---|---|
| 5 March 2024 | ID | 30021500 | Rituximab 10Mg/Ml (Rituximab Api) | PT Kalbio Global Medika | ID | Mabxience Research S L | $837,935.30 | |
| 20 December 2023 | ID | 30033100 | Insulin Glargine Baik, Baru | PT Kalbio Global Medika | ID | Gan & Lee Pharmaceuticals | $802,681.60 | |
| 25 April 2024 | ID | 30021500 | Rituximab 10Mg/Ml (Rituximab Api) . Batch #010123011 | PT Kalbio Global Medika | ID | Mabxience Research S L | $784,429.60 | |
| 18 September 2024 | ID | 30021500 | Rituximab 10Mg/Ml (Rituximab Api) Batch #010123012 | PT Kalbio Global Medika | ID | Mabxience Research S L | $782,194.80 | |
| 23 October 2024 | ID | 30021500 | Rituximab 10Mg/Ml (Rituximab Api) Batch #010124003 | PT Kalbio Global Medika | ID | Mabxience Research S L | $778,154.40 | |
| 16 February 2022 | ID | 30033100 | Insulin Glargine Baik Baru | PT Kalbio Global Medika | ID | Gan & Lee Pharmaceuticals | CN | $750,000.00 |
| 24 May 2025 | ID | 30021500 | Rituximab 10Mg/Ml (Rituximab Api), Batch 010124006 | PT Kalbio Global Medika | ID | Mabxience Research S L | $747,266.80 | |
| 27 August 2025 | ID | 30021500 | Rituximab 10Mg/Ml (Rituximab Api)batch : 010124007 | PT Kalbio Global Medika | ID | Mabxience Research S L | $740,765.90 | |
| 17 July 2023 | ID | 30033100 | Insulin Glargine Baik, Baru | PT Kalbio Global Medika | ID | Gan & Lee Pharmaceuticals | $735,227.20 | |
| 13 November 2023 | ID | 30021500 | Rituximab 10Mg/Ml (Rituximab Api) Baik Baru | PT Kalbio Global Medika | ID | Mabxience Research S L | $671,315.72 |
0 of 20 row(s) selected.